The Serum Institute of India has announced its ongoing efforts to develop a vaccine for mpox, which has recently been declared a public health emergency by the World Health Organization (WHO). CEO Adar Poonawalla stated that the institute is committed to addressing this emerging health threat using its extensive experience in vaccine development. The initiative is crucial as mpox cases rise, with the potential for global spread. The Serum Institute plans to collaborate with global health authorities to ensure the vaccine is safe, effective, and accessible. This effort reflects the institute’s dedication to global health and combating infectious diseases.
